NCT00400556View on ClinicalTrials.gov

ATRA Plus G-CSF for Mobilization of Hematopoietic Stem and Progenitor Cells

PHASE1CompletedINTERVENTIONAL
Enrollment

6

Participants

Timeline

Start Date

March 31, 2005

Study Completion Date

May 31, 2005

Conditions
Multiple MyelomaCutaneous Lymphoma
Interventions
DRUG

ATRA plus G-CSF (filgrastim, NEUPOGEN (R)) combination

Trial Locations (1)

3002

Peter MacCallum Cancer Center, East Melbourne

All Listed Sponsors
collaborator

The Leukemia and Lymphoma Society

OTHER

lead

Peter MacCallum Cancer Centre, Australia

OTHER

NCT00400556 - ATRA Plus G-CSF for Mobilization of Hematopoietic Stem and Progenitor Cells | Biotech Hunter | Biotech Hunter